SOX2 and pancreatic neoplasm: To determine the functional relevance of SOX2 expression with gemcitabine sensitivity in pancreatic cancer cells, we knocked down SOX2 expression by two independent shRNA constructs in the gemcitabine resistant cell lines and treated with gemcitabine afterwards.